PEMETREXED VERSUS PEMETREXED PLUS CARBOPLATIN IN PRETREATED PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER: A POOLED ANALYSIS OF TWO RANDOMIZED TRIALS

被引：0
|
作者：
Tiseo, Marcello [1 ]
Ardizzoni, Andrea [1 ]
Boni, Luca [2 ]
Vincent, A. [3 ]
Buti, S.
Camerini, Andrea
Labianca, R. [4 ]
Genestreti, Giovenzio [5 ]
Zanelli, Francesca [6 ]
Ciuffreda, L. [7 ]
Di Costanzo, F. [8 ]
De Marinis, F. [9 ]
Crino, Lucio [10 ]
Santo, A. [11 ]
Pazzola, A. [12 ]
Barbieri, F. [13 ]
Zilembo, N. [14 ]
Colantonio, I. [15 ]
Tibaldi, C. [16 ]
Smit, Egbert F. [17 ]
机构：
[1] Univ Hosp Parma, Med Oncol Unit, Parma, Italy
[2] Ist Toscano Tumori, Coordinamento Sperimentaz Clin 4Ctr, Genoa, Italy
[3] Natl Canc Inst, Amsterdam, Netherlands
[4] Osped Riuniti Bergamo, Bergamo, Italy
[5] Irst Meldola, Oncol, Melola, Italy
[6] Osped Reggio Emilia, Reggio Emilia, Italy
[7] Osped Molinette, Molinette, Italy
[8] Osped Careggi, Florence, Italy
[9] San Camillo Forlanini, Rome, Italy
[10] Osped Perugia, Perugia, Italy
[11] Osped Verona, Verona, Italy
[12] Osped Sassari, Sassari, Italy
[13] Policlin Modena, Modena, Italy
[14] Ist Nazl Tumori, Naples, Italy
[15] Osped Cuneo, Cuneo, Italy
[16] Osped Livorno, Livorno, Italy
[17] Vrije Univ, Med Ctr, Pulmonol Dept, Amsterdam, Netherlands
来源：
JOURNAL OF THORACIC ONCOLOGY | 2011年 / 6卷 / 06期
关键词：
NSCLC; second-line chemotherapy; Pemetrexed; Carboplatin;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页码：S415 / S415
页数：1
相关论文
共 50 条
  • [21] Pemetrexed monotherapy versus pemetrexed plus platinum combination as second-line treatment for advanced non-small cell lung cancer
    ZHANG Yifei CHEN Zhiwei LU Shun Shanghai Lung Tumor Clinical Medical CenterChest Hospital Affiliated to Shanghai Jiao Tong UniversityShanghai China
    中华医学杂志(英文版), 2009, (20) : 2472 - 2476
  • [22] The use of pemetrexed in advanced non-small cell lung cancer
    Ng, C.
    Harris, M. A.
    Burt, P. A.
    Sheikh, H. S.
    Lee, L.
    Blackhall, F. H.
    Summers, Y.
    Taylor, P.
    Coote, J.
    Chittalia, A.
    Califano, R.
    Bayman, N.
    LUNG CANCER, 2014, 83 : S12 - S12
  • [23] 65 plus: A randomized phase III trial of pemetrexed and bevacizumab versus pemetrexed, bevacizumab, and carboplatin as first-line treatment for elderly patients with advanced nonsquamous, non-small cell lung cancer (NSCLC).
    Schuette, Wolfgang
    Nagel, Sylke
    Schneider, Claus-Peter
    Engel-Riedel, Walburga
    Schumann, Christian
    Kohlhaeufl, Martin
    Serke, Monika
    Hoeffken, Gert
    Kortsik, Cornelius
    Reck, Martin
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [24] Pemetrexed for treatment of advanced non-small cell lung cancer
    Fossella, FV
    SEMINARS IN ONCOLOGY, 2004, 31 (01) : 100 - 105
  • [25] A Randomized Phase II Study of Maintenance Bevacizumab, Pemetrexed or Bevacizumab Plus Pemetrexed for Advanced Non-squamous Non-small Cell Lung Cancer
    Yoshida, Hironori
    Kim, Young Hak
    Sakamori, Yuichi
    Nagai, Hiroki
    Ozasa, Hiroaki
    Kaneda, Toshihiko
    Yoshioka, Hiroshige
    Nakagawa, Hiroaki
    Tomii, Keisuke
    Okada, Asuka
    Yoshimura, Kenichi
    Hirabayashi, Masataka
    Hirai, Toyohiro
    ANTICANCER RESEARCH, 2020, 40 (05) : 2981 - 2987
  • [26] Pharmacogenetic study of patients with advanced non-small cell lung cancer (NSCLC) treated with second-line pemetrexed or pemetrexed-carboplatin
    Tiseo, Marcello
    Giovannetti, Elisa
    Tibaldi, Carmelo
    Camerini, Andrea
    Di Costanzo, Francesco
    Barbieri, Fausto
    Burgers, Jacobus A.
    Vincent, Andrew
    Peters, Godefridus J.
    Smith, Egbert F.
    Ardizzoni, Andrea
    LUNG CANCER, 2012, 78 (01) : 92 - 99
  • [27] Pemetrexed and carboplatin plus bevacizumab for advanced non-squamous non-small cell lung cancer (NSCLC): Preliminary results
    Patel, J. D.
    Hensing, T. A.
    Villafor, V.
    Hart, E.
    Bonomi, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [28] Randomized study of gefitinib versus pemetrexed as maintenance treatment in patients with advanced glandular non-small cell lung cancer
    Xu, Yan-Hua
    Mei, Jing-Song
    Zhou, Juan
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (04): : 6242 - 6246
  • [29] Pemetrexed for advanced non-small cell lung cancer patients with interstitial lung disease
    Kato M.
    Shukuya T.
    Takahashi F.
    Mori K.
    Suina K.
    Asao T.
    Kanemaru R.
    Honma Y.
    Muraki K.
    Sugano K.
    Shibayama R.
    Koyama R.
    Shimada N.
    Takahashi K.
    BMC Cancer, 14 (1)
  • [30] Risk Factors for Predicting Severe Neutropenia Induced by Pemetrexed Plus Carboplatin Therapy in Patients with Advanced Non-small Cell Lung Cancer
    Ikesue, Hiroaki
    Watanabe, Hiroyuki
    Hirano, Megumi
    Chikamori, Ayako
    Suetsugu, Kimitaka
    Ryokai, Yuriko
    Egashira, Nobuaki
    Yamada, Tsuyoshi
    Ikeda, Munehiko
    Iwama, Eiji
    Harada, Taishi
    Takayama, Koichi
    Nakanishi, Yoichi
    Masuda, Satohiro
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2015, 38 (08) : 1192 - 1198
12345